RhumbLine Advisers’s Cigna CI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$150M Sell
545,690
-20,811
-4% -$5.88M 0.11% 134
2026
Q1
$151M Buy
566,501
+2,038
+0.4% +$564K 0.13% 128
2025
Q4
$155M Buy
564,463
+8,908
+2% +$2.5M 0.13% 125
2025
Q3
$160M Sell
555,555
-18,668
-3% -$5.52M 0.13% 126
2025
Q2
$190M Sell
574,223
-11,700
-2% -$3.77M 0.16% 105
2025
Q1
$193M Buy
585,923
+4,423
+0.8% +$1.33M 0.18% 94
2024
Q4
$161M Sell
581,500
-7,386
-1% -$2.35M 0.14% 111
2024
Q3
$204M Sell
588,886
-30,470
-5% -$10.5M 0.18% 92
2024
Q2
$205M Sell
619,356
-26,353
-4% -$9.09M 0.19% 89
2024
Q1
$235M Buy
645,709
+16,311
+3% +$5.37M 0.23% 79
2023
Q4
$188M Sell
629,398
-21,116
-3% -$6.17M 0.2% 94
2023
Q3
$186M Sell
650,514
-4,175
-0.6% -$1.19M 0.22% 84
2023
Q2
$184M Sell
654,689
-1,712
-0.3% -$446K 0.21% 89
2023
Q1
$168M Sell
656,401
-14,003
-2% -$4.08M 0.21% 91
2022
Q4
$222M Buy
670,404
+36,226
+6% +$11.5M 0.3% 65
2022
Q3
$176M Sell
634,178
-3,354
-0.5% -$944K 0.26% 72
2022
Q2
$168M Sell
637,532
-14,292
-2% -$3.68M 0.25% 70
2022
Q1
$156M Buy
651,824
+9,481
+1% +$2.22M 0.2% 89
2021
Q4
$148M Sell
642,343
-1,820
-0.3% -$387K 0.18% 98
2021
Q3
$129M Buy
644,163
+10,115
+2% +$2.2M 0.17% 102
2021
Q2
$150M Sell
634,048
-35,142
-5% -$8.78M 0.2% 91
2021
Q1
$162M Sell
669,190
-51,125
-7% -$11.4M 0.22% 81
2020
Q4
$150M Sell
720,315
-17,009
-2% -$3.34M 0.21% 91
2020
Q3
$125M Buy
737,324
+7,605
+1% +$1.34M 0.2% 95
2020
Q2
$137M Buy
729,719
+17,040
+2% +$3.23M 0.23% 81
2020
Q1
$126M Buy
712,679
+1,692
+0.2% +$328K 0.26% 68
2019
Q4
$145M Sell
710,987
-1,639
-0.2% -$301K 0.24% 73
2019
Q3
$108M Buy
712,626
+21,057
+3% +$3.43M 0.2% 96
2019
Q2
$109M Sell
691,569
-19,889
-3% -$3.12M 0.2% 92
2019
Q1
$114M Buy
711,458
+219
+0% +$40K 0.22% 84
2018
Q4
$135M Buy
711,239
+258,714
+57% +$54M 0.29% 63
2018
Q3
$94.2M Sell
452,525
-3,437
-0.8% -$637K 0.18% 111
2018
Q2
$77.5M Buy
455,962
+1,035
+0.2% +$179K 0.16% 130
2018
Q1
$76.3M Sell
454,927
-14,749
-3% -$2.87M 0.16% 130
2017
Q4
$95.4M Sell
469,676
-5,069
-1% -$1.01M 0.19% 103
2017
Q3
$88.7M Buy
474,745
+21,612
+5% +$3.85M 0.19% 105
2017
Q2
$75.8M Sell
453,133
-8,477
-2% -$1.36M 0.17% 117
2017
Q1
$67.6M Buy
461,610
+12,945
+3% +$1.91M 0.16% 127
2016
Q4
$59.8M Buy
448,665
+30,355
+7% +$3.97M 0.15% 136
2016
Q3
$54.5M Buy
418,310
+16,208
+4% +$2.12M 0.15% 137
2016
Q2
$51.5M Buy
402,102
+14,819
+4% +$1.96M 0.15% 132
2016
Q1
$53.2M Buy
387,283
+12,673
+3% +$1.74M 0.16% 122
2015
Q4
$54.8M Buy
374,610
+844
+0.2% +$116K 0.18% 114
2015
Q3
$50.5M Buy
373,766
+3,869
+1% +$562K 0.17% 119
2015
Q2
$59.9M Buy
369,897
+34,558
+10% +$4.77M 0.19% 105
2015
Q1
$43.4M Sell
335,339
-11,312
-3% -$1.31M 0.13% 167
2014
Q4
$35.7M Sell
346,651
-7,242
-2% -$714K 0.1% 192
2014
Q3
$32.1M Sell
353,893
-9,291
-3% -$868K 0.1% 197
2014
Q2
$33.4M Sell
363,184
-25,567
-7% -$2.19M 0.1% 195
2014
Q1
$32.5M Sell
388,751
-15,880
-4% -$1.31M 0.1% 193
2013
Q4
$35.4M Sell
404,631
-12,013
-3% -$983K 0.1% 185
2013
Q3
$32M Buy
416,644
+3,260
+0.8% +$255K 0.1% 193
2013
Q2
$30M Buy
+413,384
New +$27.9M 0.1% 199

Other funds holding CI

RhumbLine Advisers's CI Position: Q2 2026 in Review

RhumbLine Advisers reduced its Cigna (CI) stake by 3.7% in Q2 2026, selling an estimated $5.88M and leaving 545,690 shares worth $150M. The position accounts for 0.11% of the portfolio, ranked #134.

RhumbLine Advisers first reported a position in CI in Q2 2013 and has held it in 53 quarters since. The position peaked at $235M in Q1 2024. 1,699 funds tracked by Wall St. Rank hold CI as of Q2 2026.

  • RhumbLine Advisers held 545,690 shares of Cigna worth $150M as of Q2 2026.
  • RhumbLine Advisers sold 20,811 Cigna shares in Q2 2026, an estimated $5.88M.
  • Cigna made up 0.11% of RhumbLine Advisers's portfolio in Q2 2026, its #134 holding.
  • RhumbLine Advisers first reported a position in Cigna in Q2 2013 and has held it in 53 quarters since.
  • RhumbLine Advisers's Cigna position peaked at $235M in Q1 2024.
  • 1,699 funds tracked by Wall St. Rank held Cigna as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.